AOD9604 – 5mg

AOD9604 is a synthetic peptide fragment derived from the C terminal region of human growth hormone, specifically the amino acid sequence 177-191 of the HGH molecule. Engineered to isolate the lipolytic activity of growth hormone while eliminating its growth promoting and insulin desensitizing effects. Hudson Science’s formulation supplies 5mg as a lyophilized vial, preserving peptide structural integrity and potency across storage conditions until reconstitution, standard practice for HGH derived peptide fragments where aqueous stability at ambient temperature is limited.

AOD9604’s mechanism of action centers on its selective stimulation of lipolysis and inhibition of lipogenesis through beta-3 adrenergic receptor pathway activation in adipose tissue. The same mechanism responsible for HGH’s fat mobilizing effects but isolated from the IGF-1 mediated anabolic and mitogenic activity of the full length growth hormone molecule. By targeting only the 177-191 C-terminal fragment responsible for fat metabolism signaling, AOD9604 produces documented lipolytic activity in adipose tissue research models without the growth factor receptor stimulation, insulin resistance, and IGF-1 elevation associated with full length HGH administration. This selective mechanism has made AOD9604 a frequently studied compound in obesity and body composition research examining growth hormone derived peptide fragments as targeted metabolic research tools.

AOD9604’s regulatory history adds a meaningful research context that distinguishes it from most peptide compounds. It was granted FDA Generally Recognized as Safe (GRAS) status. An unusual regulatory designation for a synthetic peptide that reflects its documented safety profile across clinical investigation and positions it as one of the more extensively human safety characterized HGH fragment peptides in current research. This GRAS designation and the clinical investigation data underpinning it contribute a human safety literature base that most lipolytic research peptides lack, making AOD9604 a valuable reference compound in comparative metabolic peptide safety and efficacy research.

Hudson Science formulations are stocked by Canada Steroid Depot following the same rigorous third party lab verification process applied to every product in our range. Each batch is tested for concentration accuracy and purity before being made available, with COA documentation available on request. CSD’s sourcing standards apply uniformly across all manufacturers we carry, and Hudson Science’s AOD9604 meets those standards consistently. All orders ship discreetly across Canada in plain, unmarked packaging with no identifying information on the exterior.

Reconstitute with bacteriostatic water prior to use. Store lyophilized peptide at 2–8°C away from direct light. Once reconstituted refrigerate and use within 28 days. Intended for research purposes only.

Commonly researched alongside L-Carnitine and metabolic peptide compounds in comparative lipolytic activity and body composition studies. Browse CSD’s full peptide range for complete sourcing.